Staphylococcus aureus Alpha-Toxin Limits Type 1 While Fostering Type 3 Immune Responses

Agnes Bonifacius, Oliver Goldmann, Stefan Floess, Silva Holtfreter, Philippe A. Robert, Maria Nordengrün, Friederike Kruse, Matthias Lochner, Christine S. Falk, Ingo Schmitz, Barbara M. Bröker, Eva Medina, Jochen HuehnFrontiers in Immunology 2020 · DOI

TL;DR

This study reveals that Staphylococcus aureus alpha-toxin, a key virulence factor, actively manipulates the host immune system. It selectively kills Type 1 T helper cells (Th1) while sparing Type 3 T helper cells (Th17), effectively shifting the immune response towards a Th17-dominant profile. This finding has significant implications for developing new therapeutic strategies against antibiotic-resistant S. aureus infections.

What Problem Does This Paper Address?

Staphylococcus aureus is a major cause of serious infections, and the rise of antibiotic resistance makes effective treatments increasingly challenging. Developing new therapies, such as vaccines or immune-based treatments, hinges on a deep understanding of how S. aureus evades the host immune system. While alpha-toxin is known to damage tissues by disrupting the epithelial barrier, its direct impact on immune cells, particularly T cells, and how this contributes to infection outcomes, remained less understood. Specifically, the paper addresses the question of whether alpha-toxin directly influences the differentiation and survival of different CD4+ T cell subsets, which are crucial for fighting S. aureus infections.

Methods

The researchers employed a multi-pronged approach combining in vitro cell culture experiments with in vivo mouse infection models.

  • In vitro T cell differentiation: Naive CD4+ T cells from mice were cultured under conditions that promote differentiation into either Th1 or Th17 cells. Alpha-toxin was added to these cultures at varying concentrations to assess its effects.
  • Flow Cytometry: This was the primary technique used to analyze cell populations. It was employed to measure:
  • Cell survival and death (using fixable viability dyes).
  • Cell proliferation (using CellTrace™ Violet dye).
  • Expression of key transcription factors (T-bet for Th1, RORγt for Th17) and effector cytokines (IFNγ for Th1, IL-17A for Th17).
  • Expression of the alpha-toxin receptor, ADAM10.
  • Caspase-3/7 activity to assess apoptosis.
  • Pharmacological Inhibition: An ADAM10 inhibitor (GI254023X) and a pan-caspase inhibitor (Q-VD) were used to investigate the mechanisms of alpha-toxin-induced cell death.
  • In vivo infection model: Mice were infected intravenously with either wild-type S. aureus or an alpha-toxin-deficient (Δhla) mutant strain.
  • Post-infection Analysis: Spleens and lymph nodes were collected from infected mice to analyze immune cell populations (CD4+ T cells, γδ T cells, and innate lymphoid cells) using flow cytometry. Serum was also collected to measure cytokine and chemokine levels.

Datasets

Not discussed in the paper. The study primarily relies on experimental data generated from cell cultures and animal models.

Key Insights and Ideas

  • Alpha-toxin is a sophisticated immune modulator: Beyond its tissue-damaging role, alpha-toxin actively shapes the adaptive immune response by selectively targeting specific T cell subsets.
  • Differential susceptibility of T cell subsets: Th1 cells are highly vulnerable to alpha-toxin-induced death, while Th17 cells exhibit remarkable resistance. This is a key finding that explains the shift in immune balance.
  • Calcium signaling as a potential mechanism: The increased susceptibility of Th1 cells to ionomycin-induced cell death suggests that alpha-toxin might exploit calcium signaling pathways to induce cell death in Th1 cells, a pathway to which Th17 cells are less sensitive.
  • Alpha-toxin's broad impact: The effect isn't limited to CD4+ T cells; alpha-toxin also influences γδ T cells and innate lymphoid cells (ILCs), suggesting a more general strategy to suppress Type 1 immunity and promote Type 3 immunity.
  • In vivo validation: The in vitro findings are mirrored in a mouse model of S. aureus bacteremia, where alpha-toxin deficiency leads to a restoration of Th1 cell numbers and a reduction in Th17 cells.

Key Results

  • Differential Survival: In vitro, increasing concentrations of alpha-toxin led to a dose-dependent decrease in viable Th1 cells, while Th17 cell viability remained largely unaffected.
  • Proliferation: Alpha-toxin slightly enhanced Th17 cell proliferation but had minimal impact on Th1 cell proliferation.
  • Transcription Factor and Cytokine Expression: Alpha-toxin had little to no effect on the expression of key transcription factors (T-bet, RORγt) but showed a trend towards slightly increased IFNγ and IL-17A production in Th1 and Th17 cells, respectively.
  • ADAM10 and Caspase Independence: The differential susceptibility was not explained by varying levels of the alpha-toxin receptor ADAM10 or by caspase activation. Inhibition of ADAM10 did not rescue Th1 cells, and caspase inhibition also failed to prevent alpha-toxin-induced Th1 cell death.
  • In vivo immune shift: In mice infected with wild-type S. aureus, there was a significant decrease in T-bet+ (Th1) CD4+ T cells and a significant increase in RORγt+ (Th17) CD4+ T cells compared to mice infected with the alpha-toxin-deficient mutant.
  • Impact on other immune cells: Alpha-toxin also reduced T-bet+ γδ T cells and Type 1 ILCs, while increasing RORγt+ γδ T cells in vivo.

Limitations and Future Work

  • Mechanism of Th1 cell death: While calcium signaling is implicated, the precise molecular mechanisms by which alpha-toxin induces caspase-independent cell death in Th1 cells remain to be fully elucidated. The authors suggest using genetically encoded calcium sensors for further investigation.
  • ADAM10's role at low concentrations: The study notes that ADAM10 is crucial for alpha-toxin binding at low concentrations (around 10 ng/ml), and suggests that differences in membrane composition between Th1 and Th17 cells might contribute to their differential susceptibility, a hypothesis that requires further testing.
  • Indirect effects of alpha-toxin in vivo: The authors acknowledge that alpha-toxin might indirectly affect T-bet+ cells in vivo by inducing inflammatory mediators from accessory cells, such as IL-1β, which can then influence T cell responses.
  • Early vs. late effects: The study observed long-term effects on Type 1 ILCs but not Type 3 ILCs, suggesting that Type 3 ILCs might be affected early in infection and rapidly normalize.
  • Therapeutic potential: The findings open avenues for developing novel immune-based therapies by targeting alpha-toxin or by selectively modulating immune responses to favor Type 3 immunity, particularly for combating antibiotic-resistant S. aureus.

Summary updated

Abstract

Staphylococcus aureus can cause life-threatening diseases, and hospital- as well as community-associated antibiotic-resistant strains are an emerging global public health problem. Therefore, prophylactic vaccines or immune-based therapies are considered as alternative treatment opportunities. To develop such novel treatment approaches, a better understanding of the bacterial virulence and immune evasion mechanisms and their potential effects on immune-based therapies is essential. One important staphylococcal virulence factor is alpha-toxin, which is able to disrupt the epithelial barrier in order to establish infection. In addition, alpha-toxin has been reported to modulate other cell types including immune cells. Since CD4+ T cell-mediated immunity is required for protection against S. aureus infection, we were interested in the ability of alpha-toxin to directly modulate CD4+ T cells. To address this, murine naïve CD4+ T cells were differentiated in vitro into effector T cell subsets in the presence of alpha-toxin. Interestingly, alpha-toxin induced death of Th1-polarized cells, while cells polarized under Th17 conditions showed a high resistance towards increasing concentrations of this toxin. These effects that could neither be explained by differential expression of the cellular alpha-toxin receptor ADAM10 nor by differential activation of caspases, but might results from an increased susceptibility of Th1 cells towards Ca2+-mediated activation-induced cell death. In accordance with the in vitro findings, an alpha-toxin-dependent decrease of Th1 and concomitant increase of Th17 cells was observed in vivo during S. aureus bacteremia. Interestingly, corresponding subsets of innate lymphoid cells and γδ T cells were similarly affected, suggesting a more general effect of alpha-toxin on the modulation of type 1 and type 3 immune responses. In conclusion, we have identified a novel alpha-toxin-dependent immunomodulatory strategy of S. aureus, which can directly act on CD4+ T cells and might be exploited for the development of novel immune-based therapeutic approaches to treat infections with antibiotic-resistant S. aureus strains.
BibTeX
@inproceedings{bonifacius2020staphylococcus,
  author = {Agnes Bonifacius and Oliver Goldmann and Stefan Floess and Silva Holtfreter and Philippe A. Robert and Maria Nordengrün and Friederike Kruse and Matthias Lochner and Christine S. Falk and Ingo Schmitz and Barbara M. Bröker and Eva Medina and Jochen Huehn},
  title = {{Staphylococcus aureus Alpha-Toxin Limits Type 1 While Fostering Type 3 Immune Responses}},
  booktitle = {Frontiers in Immunology},
  year = {2020},
  doi = {10.3389/fimmu.2020.01579},
}
Figure